International Multiple Sclerosis Registry

International Multiple Sclerosis Registry
Name	International Multiple Sclerosis Registry
Formation	20XX
Type	Research registry
Headquarters	Geneva, Switzerland
Leader title	Director
Leader name	Dr. Jane Doe

International Multiple Sclerosis Registry

The International Multiple Sclerosis Registry is a multinational research repository designed to aggregate clinical, genetic, imaging, and epidemiological data on Multiple sclerosis from cohorts across United States, United Kingdom, Germany, France, and other countries. It supports collaborative studies with institutions such as World Health Organization, National Institutes of Health, European Commission, Bill & Melinda Gates Foundation, and university centers including University of Oxford, Harvard University, Karolinska Institutet, and University of Toronto. The registry facilitates translational research linking datasets from hospital systems like Mayo Clinic, Cleveland Clinic, and research networks such as Consortium of Multiple Sclerosis Centers and European Multiple Sclerosis Platform.

Overview

The registry functions as a centralized platform coordinating longitudinal datasets, connecting clinical sites including Johns Hopkins Hospital, Massachusetts General Hospital, Imperial College London, Charité – Universitätsmedizin Berlin, and biobanks like UK Biobank and European Genome-phenome Archive. It integrates imaging contributions from centers operating Magnetic resonance imaging scanners at institutions such as Stanford University, University College London, McGill University, and genetic sequencing data from labs linked to Wellcome Trust Sanger Institute, Broad Institute, and Max Planck Society. Partner organizations include advocacy groups like National Multiple Sclerosis Society, MS International Federation, and patient registries run by Canadian Institutes of Health Research collaborators.

History and Development

The registry was conceived after international meetings involving stakeholders from World Health Organization, European Commission', and research consortia including International Progressive MS Alliance and International Advisory Committee on Clinical Trials in Multiple Sclerosis. Early pilots drew on data harmonization efforts pioneered by Human Genome Project collaborators at Wellcome Trust, and registry models from Surveillance, Epidemiology, and End Results Program and Framingham Heart Study. Expansion phases included partnerships with national health systems such as NHS England, Rijksinstituut voor Volksgezondheid en Milieu, and outreach to centers in Brazil, India, South Africa, and Japan.

Governance and Funding

Governance is overseen by an international board with representatives from World Health Organization, European Medicines Agency, National Institutes of Health, Global Fund to Fight AIDS, Tuberculosis and Malaria, and academic leaders from University of California, San Francisco, Yale University, University of Melbourne, and University of São Paulo. Funding combines grants from entities like Wellcome Trust, European Research Council, and philanthropic support from Fondation Botnar, Howard Hughes Medical Institute, and corporate partnerships with pharmaceutical companies including Novartis, Biogen, and Roche. Operational policies align with standards set by Organisation for Economic Co-operation and Development, Council of Europe, and ethics frameworks referenced by International Committee of Medical Journal Editors.

Data Collection and Methodology

Data acquisition harmonizes clinical scales such as the Expanded Disability Status Scale collected at sites including Karolinska Institutet and Brigham and Women's Hospital, standardized imaging protocols informed by groups like North American Imaging in Multiple Sclerosis Cooperative, and genomics pipelines using platforms developed at Broad Institute and Sanger Institute. Methodological frameworks incorporate biostatistics practices from Cochrane Collaboration, machine learning collaborations with DeepMind, and data standards promoted by Health Level Seven International. Cohort linkage leverages electronic health record networks exemplified by Observational Health Data Sciences and Informatics and federated analysis tools influenced by GA4GH initiatives.

Research Outputs and Impact

Published outputs include epidemiological analyses comparing prevalence across regions such as Scandinavia, Mediterranean Basin, and North America, prognostic biomarker studies with collaborators at University of Cambridge and University of Edinburgh, and therapeutic response research involving clinical trial networks like European Clinical Research Infrastructure Network and National Clinical Research Network. Findings have influenced regulatory guidance from European Medicines Agency and clinical practice recommendations referenced by American Academy of Neurology and Royal College of Physicians. The registry has enabled high-impact studies cited alongside work from International Multiple Sclerosis Genetics Consortium, ENIGMA Consortium, and meta-analyses published in journals associated with Nature Publishing Group and The Lancet.

Privacy, Ethics, and Data Sharing

Privacy frameworks follow models from General Data Protection Regulation and ethical oversight by institutional review boards at University of Pennsylvania, Trinity College Dublin, and University of Zurich. Data sharing policies implement controlled-access mechanisms similar to dbGaP and governance structures inspired by Global Alliance for Genomics and Health. Consent templates reflect standards used by the Human Cell Atlas and patient engagement strategies align with practices from PatientsLikeMe and European Patients' Academy.

Participation and Enrollment Criteria

Enrollment criteria require confirmed diagnoses consistent with diagnostic guidelines from McDonald criteria and referral from neurologists at centers like Mayo Clinic and Hospital for Sick Children (Toronto). Inclusion balances demographic representation across regions including Sub-Saharan Africa, East Asia, Latin America, and Oceania and includes pediatric cohorts worked with through partnerships with UNICEF-linked programs. Enrollment logistics employ electronic consent platforms developed in collaboration with Microsoft research teams and participant portals modeled after systems at University of Michigan and Duke University.

Category:Multiple sclerosis Category:Medical registries